Abstract
In the past 20 years, photosensitisers have found a niche in the photodynamic treatment of accessible tumours (PDT). Most of the therapeutics involved in this approach are porphyrin-based natural products or derivatives. However, there is a range of other photodynamic agents derived from natural sources – either via direct extraction/purification, or via semisynthesis - currently being trialled both for anticancer PDT and the related antimicrobial application, covering areas such as wound disinfection and blood product sterilisation. The following review covers the advances made in the potential photoantimicrobial application of natural product photosensitisers and their derivatives.
Keywords: Antimicrobial, photosensitiser, singlet oxygen, porphyrin, perylenequinonoid, anthraquinone, isoquinoline, furocoumarin
Current Bioactive Compounds
Title: Natural Product Photoantimicrobials
Volume: 3 Issue: 4
Author(s): M. Wainwright
Affiliation:
Keywords: Antimicrobial, photosensitiser, singlet oxygen, porphyrin, perylenequinonoid, anthraquinone, isoquinoline, furocoumarin
Abstract: In the past 20 years, photosensitisers have found a niche in the photodynamic treatment of accessible tumours (PDT). Most of the therapeutics involved in this approach are porphyrin-based natural products or derivatives. However, there is a range of other photodynamic agents derived from natural sources – either via direct extraction/purification, or via semisynthesis - currently being trialled both for anticancer PDT and the related antimicrobial application, covering areas such as wound disinfection and blood product sterilisation. The following review covers the advances made in the potential photoantimicrobial application of natural product photosensitisers and their derivatives.
Export Options
About this article
Cite this article as:
Wainwright M., Natural Product Photoantimicrobials, Current Bioactive Compounds 2007; 3 (4) . https://dx.doi.org/10.2174/157340707783220202
DOI https://dx.doi.org/10.2174/157340707783220202 |
Print ISSN 1573-4072 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6646 |
![](/images/wayfinder.jpg)
- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Opioid Free Anaesthesia and Cancer
Current Pharmaceutical Design Targeting p73 - a Potential Approach in Cancer Treatment
Current Pharmaceutical Design New Insights Into the Molecular Mechanisms of Action of Bisphosphonates
Current Pharmaceutical Design An Overview on Keratinocyte Growth Factor: From the Molecular Properties to Clinical Applications
Protein & Peptide Letters Peptidyl Prolyl Isomerase, Pin1 is a Potential Target for Enhancing the Therapeutic Efficacy of Etoposide
Current Cancer Drug Targets Recent Patents Relating To HCV Molecules Like Putative Targets For Therapeutic Intervention
Recent Patents on DNA & Gene Sequences Gene Delivery System: A Developing Arena of Study for the New Era of Medicine
Recent Patents on DNA & Gene Sequences Cancer Stem Cells and their Management in Cancer Therapy
Recent Patents on Anti-Cancer Drug Discovery Recent Advances in Immune Modulation
Current Gene Therapy Mechanism of Tau-Induced Neurodegeneration in Alzheimer Disease and Related Tauopathies
Current Alzheimer Research γ-Secretase Substrates and their Implications for Drug Development in Alzheimer's Disease
Current Topics in Medicinal Chemistry Bioinformatics Approach to BDNF and BDNF-Related Disorders
Current Neuropharmacology Potential Application of 5-Aryl-Substituted 2-Aminobenzamide Type of HDAC1/2- Selective Inhibitors to Pharmaceuticals
Current Pharmaceutical Design Global Cell Proteome Profiling, Phospho-signaling and Quantitative Proteomics for Identification of New Biomarkers in Acute Myeloid Leukemia Patients
Current Pharmaceutical Biotechnology Gambogic Acid is a Novel Anti-cancer Agent that Inhibits Cell Proliferation, Angiogenesis and Metastasis
Anti-Cancer Agents in Medicinal Chemistry Current Molecularly Targeting Therapies in NSCLC and Melanoma
Anti-Cancer Agents in Medicinal Chemistry Detecting Growing Mammary Tumors with Monoclonal Antibodies Against Vascular Endothelial Growth Factor Receptor – 3
Current Radiopharmaceuticals 86Y Based PET Radiopharmaceuticals: Radiochemistry and Biological Applications
Medicinal Chemistry Targeting Epigenetic Modifiers in Cancer
Current Medicinal Chemistry The Application of DNA Microarrays to the Study of Cancer
Current Genomics